112 filings
Page 5 of 6
8-K
wjiak8k95xfq2 4e
2 Apr 21
Fusion Pharmaceuticals Announces Closing of Acquisition of IPN-1087, a Small Molecule Targeting NTSR1, from Ipsen
8:10am
8-K
bi7gcrgzajzqj
2 Apr 21
Departure of Directors or Certain Officers
8:00am
SEC STAFF
ildu2hu
29 Mar 21
SEC staff action: Order
12:00am
S-8
0t8v6ad64 b9xurd
25 Mar 21
Registration of securities for employees
8:16am
10-K
xjorpsax08xwqh1c62f1
25 Mar 21
Annual report
8:01am
8-K
6rgx jwwx66d7tj
25 Mar 21
Fusion Pharmaceuticals Announces Fourth Quarter 2020 Financial Results
7:46am
8-K
v35ua5ayj off7tlz
2 Mar 21
Fusion Pharmaceuticals to Expand Pipeline with Acquisition of IPN-1087, a Small Molecule Targeting NTSR1, from Ipsen
9:00am
SEC STAFF
b30lcae
1 Mar 21
SEC staff action: Order
12:00am
8-K
2k8ex4
12 Feb 21
Fusion Pharmaceuticals Appoints Philina Lee, Ph.D., to
4:16pm
8-K
6nvexvmeu9gyt 1fz2fk
10 Nov 20
Fusion Pharmaceuticals Announces Third Quarter 2020 Financial Results
7:15am
8-K
hxermq2o pckcsabp
3 Nov 20
Fusion Pharmaceuticals Appoints Barbara Duncan as Chairperson of the Board of Directors
4:10pm
8-K
2jxo3j wyi0eew96sh
2 Nov 20
Entry into a Material Definitive Agreement
7:11am
10-Q
z6u4tnk3 x1ot49p
11 Aug 20
Quarterly report
4:05pm
8-K
8efkh snpq6n9
11 Aug 20
Fusion Pharmaceuticals Announces Second Quarter 2020 Financial Results
8:30am
S-8
uho77o4
30 Jun 20
Registration of securities for employees
4:35pm
8-K
1555ard81 1289
30 Jun 20
Amendments to Articles of Incorporation or Bylaws
4:01pm
424B4
e3x dyfga
26 Jun 20
Prospectus supplement with pricing info
4:47pm
EFFECT
iwe4wzik
26 Jun 20
Notice of effectiveness
12:15am
CERT
7f7ofa
25 Jun 20
Certification of approval for exchange listing
11:50am